Comparison of expression optimization of new derivative of staphylokinase (SAK‐2RGD‐TTI) with the rSAK-Reference-Cited by-同舟云学术

Comparison of expression optimization of new derivative of staphylokinase (SAK‐2RGD‐TTI) with the rSAK

Author:

Faraji Habibollah¹,Ramezani Mohammad²,Mashkani Baratali³,Sadeghnia Hamid R.⁴⁵,Benhangi Hamid M.⁶,Hosseini Teshnizi Saeed⁷,Soltani Fatemeh⁸^ORCID

Affiliation:

1. Department of Laboratory Sciences, Faculty of Para‐MedicineHormozgan University of Medical Sciences Bandar Abbas Iran

2. Pharmaceutical Research CenterPharmaceutical Technology Institute, Mashhad University of Medical Sciences Mashhad Iran

3. Department of Medical Biochemistry, Faculty of MedicineMashhad University of Medical Sciences Mashhad Iran

4. Neurocognitive Research Center, Faculty of MedicineMashhad University of Medical Sciences Mashhad Iran

5. Department of New Sciences and Technology, Faculty of MedicineMashhad University of Medical Sciences Mashhad Iran

6. Department of ToxicologyIslamic Azad University Shahreza Isfahan Iran

7. Department of Biostatistics, School of MedicineShiraz University of Medical Science Shiraz Iran

8. Biotechnology Research CenterPharmaceutical Technology Institute, Mashhad University of Medical Sciences Mashhad Iran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Biotechnology

Link

Reference57 articles.

1. Staphylokinase: A Boon in Medical Sciences—Review;Ram KS;Mintage J Pharm Med Sci,2013

2. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity—a staphylokinase variant;Szemraj J;Thromb Haemost,2007

3. Evolutionary trend of thrombolytics;Kumar A;Int J Bio‐Sci Bio‐Technol,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献